Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Concordet, D and Gandia, P and Montastruc, J L and Bousquet-Mélou, A and Lees, P and Ferran, A and Toutain, P L (2019) Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?". Clinical Pharmacokinetics.

[img]
Preview
Text
12178.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (687kB) | Preview